Pharmacokinetics and Dynamics of Nebulized Dexmedetomidine

• Status: Unknown status
• Trial end date: 2021-01-01
• Target enrollment: 0
• Participant gender: All

Summary

the aim of this study is to study the pharmacokinetics and dynamics of nebulized dexmetedomidine in children undergoing major abdominal cancer surgery.

• Phase: Phase 1/Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Assiut University
• Treatments: Dexmedetomidine

Criteria

Inclusion Criteria:

• child aged 2-7 years

• ASA I or II

• scheduled for abdominal surgery

• with average weight, height, normal serum albumin

Exclusion Criteria:

• patients with allergy to the study drug

• patients with significant organ dysfunction

• patients with cardiac arrhythmia

• patients with congenital heart disease

• use of psychotropic medication and mental retardation.